| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
| mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.0008 |